The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

This study investigated patients with primary lung cancer who received PET/CT scan, a medical imaging test, and subsequently ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

Immunotherapy has dramatically improved the treatment outcomes of primary lung cancer; however, it sometimes causes a serious ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation ...

Blocking a protein that imports lactic acid, a metabolic byproduct of cancer cells, reinvigorated exhausted T cells and led to improved tumor control in mouse models of cancer, according to a new ...

The immune system is a major target for cancer treatments. Immune checkpoint inhibitors and CAR-T cell therapy can ...

A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous heart condition ...

Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis. Researchers have now uncovered the ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

TIL-Tregs specifically increase GLUT3 expression for glucose uptake in tumors. - GLUT3 fuels protein O-GlcNAcylation, ...

Advertisement Specific types of immune cells unleashed by cancer immunotherapy appear to cause myocarditis, an inflammatory ...